Onyx CEO Anthony Coles talks about cancer research and shares his personal story of fighting cancer. Anthony Coles, Andrew Ross Sorkin. Location: Paepcke Auditorium
Dr. Anthony Coles
Dr. Coles joined Onyx in March 2008 as President, Chief Executive Officer, and a member of its board of directors. Prior to joining Onyx, he was President, Chief Executive Officer, and a member of the board of directors of NPS Pharmaceuticals, Inc. Before joining NPS Pharmaceuticals in 2005, Dr. Coles was Senior Vice President of Commercial Operations at Vertex Pharmaceuticals Incorporated, which he joined in 2002. Beginning in 1996, he held a number of executive positions while at Bristol-Myers Squibb Company, including Senior Vice President of Strategy and Policy; Senior Vice President of Marketing and Medical Affairs, Neuroscience/Infectious Diseases/Dermatology; Vice President, Western Area Sales Cardiovascular and Metabolic Business Unit for U.S. Primary Care; and Vice President, Cardiovascular Global Marketing. From 1992 until 1996, Dr. Coles also held a number of positions of increasing responsibility at Merck & Co., Inc., including Vice President of the Hypertension and Heart Failure Business Group.
Andrew Ross Sorkin
Andrew Ross Sorkin is The New York Times’s chief mergers and acquisitions reporter and a columnist. Mr. Sorkin is also the editor of DealBook (nytimes.com/dealbook), an online daily financial report he started in 2001. In addition, Sorkin is an assistant editor of business and finance news, helping guide and shape the paper’s coverage.
Too Big to Fail: How Wall Street and Washington Fought to Save the Financial System — and Themselves is Sorkin’s first book.
Sorkin, who has appeared on NBC’s “Today” show and on “Charlie Rose” on PBS, is a frequent guest host of CNBC’s “Squawk Box.” He won a Gerald Loeb Award, one of the highest honors in business journalism, in 2004 for breaking news. He also won a Society of American Business Editors and Writers Award for breaking news in 2005 and again in 2006. In 2007, the World Economic Forum named him a Young Global Leader. In 2008 and 2009, Vanity Fair named him to its “Next Establishment” list. He was also named to the Directorship 100, a list of the most influential people on the nation’s board of directors. He is a term member of the Council on Foreign Relations.
Anthony Coles, CEO of pharmaceutical company Onyx, offers a brief opinion on the Patient Protection and Affordable Care Act -- otherwise known as "Obamacare." While Coles generally views the act as a positive development, he notes one additional area for reform.